Original Article

Prognostic Significance of Microvessel Density in Invasive Ductal Carcinoma of Breast

Abstract

Background: Breast cancer is the most common malignant tumor and cause of death in women. Factors that play role in tumor metastasis are lymph node involvement, lack of tumor differentiation and hormone receptor expression, high proliferation rate, and angiogenesis. In the present study, we tried to evaluate the microvessel density (MVD) using Immunohistochemistry for the CD34 marker to investigate the amount of angiogenesis in breast cancer and its relationship with other histopathological parameters and compare it with normal tissue.
Materials and Methods: 58 paraffin-embedded samples of breast cancer were enrolled. All blocks were sectioned and stained for estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 2(HER 2/neu), ki67, and CD34 by immunohistochemistry (IHC) method.
Results: The mean age of patients in this study was 49.6 ± 10.6 years. Statistically, there was a significant relationship between the grade of the tumor (P = 0.01), absence of expression of estrogen receptor (P = 0.008), and progesterone receptor (P = 0.003) with MVD.
Conclusion: Due to the association between MVD, tumor grade, and absence of ER and PR expression, this valuable marker can play an important role in the prediction of prognosis in breast cancer patients and can lead to new targeted therapy in the future. 

1. Şener E, Şipal S, Gündoğdu C. Comparison of microvessel density with prognostic factors in invasive ductal carcinomas of the breast. Turk J Pathol 2016;32(3):164-70.
2. Esfarjani S, Ahvazi N, Doberjovi M, et al. Comparative study of some breast cancer risk factors in patients with breast cancer and leukemia in Ahvaz Shafa Hospital. Sci Medl J. 2010;9(3):263-70.
3. Taghavi A, Fazeli Z, Vahedi M, et al. Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev. 2012;13(1):367-70.
4. Nasir A, Holzer TR, Chen M, et al. Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies. Cancer cell int. 2017;17(1):56.
5. Sun C, Li J, Wang B, et al. Tumor angiogenesis and bone metastasis-Correlation in invasive breast carcinoma. J Immunol Methods. 2018;452:46-52.
6. Chandran VI, Eppenberger-Castori S, Venkatesh T, et al. HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer. Oncoscience. 2015;2(3):207-24.
7. Lampelj M, Arko D, Cas-Sikosek N, et al. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer-correlation with traditional prognostic factors. Radiol oncol. 2015;49(4):357-64.
8. Kraby MR, Opdahl S, Akslen LA, et al. Quantifying tumour vascularity in non-luminal breast cancers. J clin pathol. 2017;70(9):766-74.
9. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 1995;36(2):169-80.
10. Chen Z, Xu S, Xu W, et al. Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance. Oncol lett. 2015;10(2):723-9.
11. Jazayeri SB, Saadat S, Ramezani R, et al. Incidence of Primary Breast Cancer in Iran: Ten-year National Cancer Registry Data Report. Cancer Epidemiol. 2015;39(4):519-27.
12. Rosai J. Rosai and Ackerman's surgical pathology e-book: Elsevier Health Sciences; 2011.
13. Bujor IS, Cioca A, CEAUȘU RA, et al. Evaluation of Vascular Proliferation in Molecular Subtypes of Breast Cancer. In Vivo. 2018;32(1):79-83.
14. Iakovlev VV, Gabril M, Dubinski W, et al. Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Lab Invest. 2012;92(1):46–56.
15. Kato T, Kimura T, Ishii N, et al. The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long‐term survival in Japanese patients with breast cancer. Breast cancer Res Treat. 1999;53(1):19-31.
16. JN, Rani P, Kamal V, et al. Angiogenesis in breast cancer and its correlation with estrogen, progesterone receptors and other prognostic factors. J Clin Diagn Res (JCDR). 2015;9(1):EC05.
17. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Human pathol. 1992;23(7):755-61
Files
IssueVol 17, No 2 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijhoscr.v17i2.12646
Keywords
Breast Cancer Microvessel densit Angiogenesis
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Abbasi A, Ghaffarizadeh F, Mojdeganlou H. Prognostic Significance of Microvessel Density in Invasive Ductal Carcinoma of Breast. Int J Hematol Oncol Stem Cell Res. 2023;17(2):100-105.